DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,919,000 | +35.9% | 95,203 | +151.6% | 0.01% | +25.0% |
Q2 2021 | $1,412,000 | -71.6% | 37,838 | -80.5% | 0.01% | -71.4% |
Q1 2021 | $4,965,000 | -25.0% | 194,166 | -35.4% | 0.03% | -28.2% |
Q4 2020 | $6,620,000 | +407.7% | 300,504 | +314.7% | 0.04% | +387.5% |
Q3 2020 | $1,304,000 | -62.3% | 72,469 | -46.8% | 0.01% | -63.6% |
Q2 2020 | $3,462,000 | -51.1% | 136,311 | -64.6% | 0.02% | -56.0% |
Q1 2020 | $7,074,000 | +12532.1% | 385,067 | +14965.2% | 0.05% | – |
Q4 2019 | $56,000 | +47.4% | 2,556 | -3.4% | 0.00% | – |
Q3 2019 | $38,000 | -96.9% | 2,645 | -97.3% | 0.00% | -100.0% |
Q2 2018 | $1,216,000 | +1588.9% | 99,233 | +1217.3% | 0.01% | – |
Q1 2018 | $72,000 | +5.9% | 7,533 | 0.0% | 0.00% | – |
Q4 2017 | $68,000 | +172.0% | 7,533 | +74.5% | 0.00% | – |
Q3 2017 | $25,000 | +47.1% | 4,318 | -17.7% | 0.00% | – |
Q2 2017 | $17,000 | -5.6% | 5,244 | 0.0% | 0.00% | – |
Q1 2017 | $18,000 | -77.8% | 5,244 | -23.1% | 0.00% | – |
Q4 2015 | $81,000 | +5.2% | 6,819 | -27.3% | 0.00% | – |
Q3 2015 | $77,000 | +60.4% | 9,379 | +174.1% | 0.00% | – |
Q2 2015 | $48,000 | – | 3,422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |